Analyst Ratings for Aerie Pharma (AERI) [Sells]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/19/2020 | BofA Securities | N/A | Downgrade | Underperform (Neutral) |
9.00 (N/A) |
11.64 (15.25) |
31.01% | Details |